CPH Chemie + Papier Holding AG
CPH Chemie + Papier Holding AG (CPHN.SW) Stock Overview
Explore CPH Chemie + Papier Holding AG’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
448.3M
P/E Ratio
96.49
EPS (TTM)
$0.78
ROE
0.02%
CPHN.SW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of CPH Chemie + Papier Holding AG (CPHN.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 63.99, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $64.62.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 96.49 and a market capitalization of 448.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
CPH Chemie + Papier Holding AG, together with its subsidiaries, engages in the developing, manufacturing, and distributing chemicals, printing paper, and pharmaceutical packaging films. The Chemistry division manufactures and distributes molecular, chromatography gels, and deuterated products under the Zeochem brand. The Paper division manufactures newsprint and magazine paper products under the Perlen Papier brand; and recycles domestically recovered paper. The Packaging division provides a range of PVC mono films and coated PVdC high-barrier films for pharmaceutical industry under the Perlen Packaging brand name. It operates in Switzerland, rest of Europe, the Americas, Asia, and internationally. The company was founded in 1818 and is headquartered in Root, Switzerland.
Gerold Brütsch CPA
959
Perlenring 1, Perlen
2001